技术指标
指标
数值
方向
MACD(12,26,9)
0.007
中性
RSI(14)
44.398
中性
STOCH(KDJ)(9,3,3)
60.117
中性
ATR(14)
0.034
高波动
CCI(14)
7.788
中性
Williams %R
42.559
买入
TRIX(12,20)
-0.809
卖出
StochRSI(14)
38.458
卖出
搜索
Avalon Globocare Corp
ALBT添加自选
0.282USD
0.0000.00%
收盘 07-21 16:00（美东）报价延迟15分钟
2.37M总市值
亏损市盈率 TTM
关键数据
--今开
0.000最高
0.00成交量
亏损市盈率 TTM
--市盈率动
--股息TTM
229.32%换手率
0.282昨收
0.000最低
0.00成交额
亏损市盈率静
-0.07市净率
0.00%股息率 TTM
-146.18%ROA
4.74052周最高
1.84量比
-7.90M净利润
4.10M总股本
-4.7087每股收益TTM
-0.07Beta
-1367.60%ROE
0.21052周最低
16.00%振幅
33.06%毛利率
2.37M总市值
-2.60回报/风险
8.15%风险率
TradingKey Avalon Globocare Corp股票评分
单位: USD 更新时间: 2026-07-21操作建议
Avalon Globocare Corp当前公司基本面数据相对谨慎，增长潜力较大。当前估值合理，在医疗设备与耗材行业排名143/203位。机构持股占比非常高，中期看，股价处于下降通道。近一个月，市场表现非常差，基本面和技术面综合得分也较低。目前股价在压力位和支撑位之间，可以做区间波段操作。
Avalon Globocare Corp评分
压力支撑
由于公司未披露，未能获取相关数据
多维评测
本期评分
上期评分
公司舆情
过去24小时
热度
过冷
过热
看空
Avalon Globocare Corp亮点
亮点风险
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
估值高估
公司最新PE估值-0.06，处于3年历史高位
机构减仓
最新机构持股83.03K股，环比减少34.57%
活跃度增加
近期活跃度增加，过去20天平均换手率0.22
分析师目标
根据
0
位分析师
--
评级
--
目标均价
--
涨幅空间
Avalon Globocare Corp新闻
即将为您带来更多新闻，敬请期待。。。
技术指标
移动平均线
指标
数值
方向
MA5
0.288
卖出
MA10
0.281
买入
MA20
0.289
卖出
MA50
0.325
卖出
MA100
0.460
卖出
MA200
0.949
卖出
财务指标
每股收益
由于公司未披露，未能获取相关数据
营业总收入
由于公司未披露，未能获取相关数据
Avalon Globocare Corp简介
Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
公司代码ALBT
公司Avalon Globocare Corp
CEOJin (David)
网址https://www.avalon-globocare.com/
公司股东
相关品种
-1.69%
-0.46%
+0.12%
-0.57%
-0.75%
+0.13%
-6.42%
-0.35%
+1.72%
-0.17%
-2.98%
+1.54%
-0.29%
-0.98%
+0.13%
+0.06%
-0.84%
-0.24%
-0.69%
-0.78%热门品种
常见问题
Avalon Globocare Corp(ALBT)的当前股价是多少？
Avalon Globocare Corp(ALBT)的当前股价是 0.28。
Avalon Globocare Corp的股票代码是什么？
Avalon Globocare Corp的股票代码是ALBT。
Avalon Globocare Corp股票的52周最高点是多少？
Avalon Globocare Corp股票的52周最高点是4.74。
Avalon Globocare Corp股票的52周最低点是多少？
Avalon Globocare Corp股票的52周最低点是0.21。
Avalon Globocare Corp的市值是多少？
Avalon Globocare Corp的市值是2.37M。
Avalon Globocare Corp(ALBT)股票的每股收益（EPS TTM）是多少
Avalon Globocare Corp(ALBT)股票的每股收益（EPS TTM）是-5.64。